Dobrobut Invests in Robotic Surgery by Acquiring the da Vinci Surgical System

Dobrobut Medical Network is expanding its high-tech surgical capabilities by investing in advanced medical technologies. The network has acquired the da Vinci Surgical System, one of the world's most widely used robotic platforms for minimally invasive surgery. For more than 25 years, the da Vinci system has been shaping the development of robotic surgery worldwide. Its introduction will give Ukrainian patients access to a technology that has become one of the global standards of modern surgical care.

The greatest advantages of the robotic system are seen during complex procedures performed in confined anatomical spaces, particularly in urology, colorectal surgery, oncology (including prostate, stomach, and rectal cancer), gynecology, and cardiac surgery. Where conventional laparoscopic techniques may have limitations, the robotic platform provides greater instrument dexterity and enables surgeons to perform highly precise movements.

For patients, this means not only less invasive surgery and a lower risk of complications, but also the possibility of performing minimally invasive procedures that previously often required open surgery. As a result, patients typically experience less postoperative pain, shorter hospital stays, and a faster return to their normal daily activities.

"The robot does not operate independently and does not replace the surgeon. It is an extension of the surgeon's hands—all clinical decisions, surgical strategy, and operative tactics remain entirely under the surgeon's control. However, the da Vinci system enables far greater precision by scaling the surgeon's movements, eliminating natural hand tremor, providing outstanding visualization, and allowing work in anatomical areas that are difficult to access with conventional instruments. During lengthy procedures, fatigue is inevitable for a human surgeon, whereas the robotic system maintains consistent stability and precision throughout the operation. Ultimately, this translates into less surgical trauma and an additional level of safety for patients," explained Yurii Lovitskyi, Head of Surgical Expertise and Quality Development at Dobrobut Medical Network.

The acquisition of the da Vinci Surgical System is part of Dobrobut's long-term strategy to advance innovative healthcare and implement technologies that have already proven their effectiveness in leading healthcare systems around the world.

"Global surgery is steadily transitioning from conventional laparoscopy to robotic technologies. According to Intuitive Surgical, the manufacturer of the da Vinci system, the number of procedures performed using da Vinci platforms in the United States continues to grow every year and reached approximately 2 million surgeries last year. An increasing number of leading medical centers worldwide are investing in robotic surgery, and Dobrobut is introducing this technology so that Ukrainian patients can benefit from internationally recognized standards of surgical care without leaving the country," said Oleksandra Mashkevych, Chief Medical Officer of Dobrobut Medical Network.